{
  "ticker": "VRTX",
  "year": 2023,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 24,
  "transactions": [
    {
      "id": 166429,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-12-15",
      "transaction_shares": "3058",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "111769"
    },
    {
      "id": 166403,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-12-13",
      "transaction_shares": "13254",
      "transaction_price": "399.41",
      "transaction_type": "S",
      "shares_after_transaction": "9171"
    },
    {
      "id": 166501,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-12-13",
      "transaction_shares": "5098",
      "transaction_price": "397",
      "transaction_type": "S",
      "shares_after_transaction": "108711"
    },
    {
      "id": 166528,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2023-12-13",
      "transaction_shares": "8603",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "65159"
    },
    {
      "id": 166484,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2023-12-05",
      "transaction_shares": "1136",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1136"
    },
    {
      "id": 166514,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2023-11-20",
      "transaction_shares": "3000",
      "transaction_price": "349.88",
      "transaction_type": "S",
      "shares_after_transaction": "46693"
    },
    {
      "id": 166466,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2023-11-15",
      "transaction_shares": "35",
      "transaction_price": "369.92",
      "transaction_type": "S",
      "shares_after_transaction": "58814"
    },
    {
      "id": 166508,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2023-11-15",
      "transaction_shares": "19",
      "transaction_price": "369.92",
      "transaction_type": "S",
      "shares_after_transaction": "32038"
    },
    {
      "id": 166439,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-11-14",
      "transaction_shares": "5650",
      "transaction_price": "380.82",
      "transaction_type": "S",
      "shares_after_transaction": "29302"
    },
    {
      "id": 166427,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2023-11-13",
      "transaction_shares": "5097",
      "transaction_price": "377",
      "transaction_type": "S",
      "shares_after_transaction": "113809"
    },
    {
      "id": 166465,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2023-11-06",
      "transaction_shares": "11250",
      "transaction_price": "127.54",
      "transaction_type": "M",
      "shares_after_transaction": "51250"
    },
    {
      "id": 166475,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-31",
      "transaction_shares": "5651",
      "transaction_price": "355.92",
      "transaction_type": "S",
      "shares_after_transaction": "34952"
    },
    {
      "id": 118572,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-17",
      "transaction_shares": "5651",
      "transaction_price": "373.25",
      "transaction_type": "S",
      "shares_after_transaction": "40603"
    },
    {
      "id": 118593,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-17",
      "transaction_shares": "243",
      "transaction_price": "375.00",
      "transaction_type": "S",
      "shares_after_transaction": "3901"
    },
    {
      "id": 166428,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-17",
      "transaction_shares": "5651",
      "transaction_price": "373.25",
      "transaction_type": "S",
      "shares_after_transaction": "40603"
    },
    {
      "id": 166453,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-17",
      "transaction_shares": "243",
      "transaction_price": "375.00",
      "transaction_type": "S",
      "shares_after_transaction": "3901"
    },
    {
      "id": 118568,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-10-16",
      "transaction_shares": "12962",
      "transaction_price": "374.00",
      "transaction_type": "S",
      "shares_after_transaction": "22425"
    },
    {
      "id": 166423,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2023-10-16",
      "transaction_shares": "12962",
      "transaction_price": "374.00",
      "transaction_type": "S",
      "shares_after_transaction": "22425"
    },
    {
      "id": 118565,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-06",
      "transaction_shares": "242",
      "transaction_price": "360.00",
      "transaction_type": "S",
      "shares_after_transaction": "4144"
    },
    {
      "id": 166420,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-06",
      "transaction_shares": "242",
      "transaction_price": "360.00",
      "transaction_type": "S",
      "shares_after_transaction": "4144"
    },
    {
      "id": 118531,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lagarde Michel",
      "reporting_owner_cik": "0001518973",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-05",
      "transaction_shares": "1132",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1132"
    },
    {
      "id": 166385,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Lagarde Michel",
      "reporting_owner_cik": "0001518973",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-05",
      "transaction_shares": "1132",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "1132"
    },
    {
      "id": 118535,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-03",
      "transaction_shares": "5651",
      "transaction_price": "345.28",
      "transaction_type": "S",
      "shares_after_transaction": "46254"
    },
    {
      "id": 166389,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2023-10-03",
      "transaction_shares": "5651",
      "transaction_price": "345.28",
      "transaction_type": "S",
      "shares_after_transaction": "46254"
    }
  ]
}